CVMP opinions on veterinary medicinal products The Committee adopted a positive opinion, in exceptional circumstances, for a marketing authorisation for Bovilis Lumpyvax(lumpy skin disease vaccine (live)),for the active immunisation of cattleto reduce clinical signs and viraemia caused by lumpy skin disease virus. The Committee adopted a positive opinion for a marketing authorisation for Stemyca (equine […]